Navigation Links
Novadaq Reports Financial Results for the First Quarter of 2008
Date:5/12/2008

performance or results. All forward-looking statements are based on Novadaq's current beliefs as well as assumptions made by and information currently available to Novadaq and relate to, among other things, results of future clinical tests of PINPOINT and the SPY System, anticipated financial performance, business prospects, strategies, regulatory developments, market acceptance and future commitments. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Due to risks and uncertainties, including the risks and uncertainties identified by Novadaq in its public securities filings actual events may differ materially from current expectations. Novadaq disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

CONSOLIDATED BALANCE SHEET

(expressed in U.S. $)

Unaudited

March 31, December 31,

2008 2007

$ $

--------------------------

ASSETS

Current

Cash and cash equivalents 7,514,062 7,417,929

Short-term investments 7,261,108 11,443,506

Accounts receivable 2,259,637 4,743,994

Current portion of prepaid expenses and

other receivables 1,119,484 1,185,707

Inventory 1,744,899 2,031,932

--------------------------

Total current assets 19,899,190
'/>"/>

SOURCE Novadaq Technologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. Novadaq Resumes Normal Business Operations by Securing ICG for SPY
2. Novadaq launches PINPOINT: Companys first minimally invasive imaging system
3. Novadaq announces third quarter 2007 conference call and webcast
4. Novadaq to present at Piper Jaffray Healthcare Conference
5. Novadaq to present at BMO Healthcare Conference
6. Novadaqs SPY Imaging System named Product of the Year by Frost and Sullivan
7. Novadaqs SPY System receives clearance for use in organ transplant surgery
8. Novadaq Data Presented at 2008 Society of Thoracic Surgeons Meeting
9. NOVADAQs SPY System to be Featured During Live Broadcast of Robotic Surgery
10. Novadaq to present at Cowen Healthcare Conference
11. Novadaq to hold fiscal 2007 year-end and fourth quarter results conference call and webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... With former ... Engineering and Math) disciplines since its inception more than 35 years ago. A pilot ... students and their teachers - and, not just those intent on pursuing careers in ...
(Date:9/1/2015)... ... September 01, 2015 , ... WorkCare, Inc., a ... its medical management team as an Associate Medical Director. , WorkCare specializes ... in the U.S. and abroad. , Dr. Nelson has a diverse background. ...
(Date:9/1/2015)... Switzerland (PRWEB) , ... September 01, 2015 , ... ... “Calibration and Qualification of Laboratory Instruments in accordance with GMP requirements“ , featuring ... presented on October 6th, 2015 at 11:00 EDT (15:00 GMT). , Calibration, ...
(Date:9/1/2015)... ... , ... Ogawa’s new massage chairs tout innovative functionality that change the way ... before. With the goal of bringing wellness to the world, Ogawa introduces their new ... As in its name, the Ogawa Refresh aims to “refresh” and rejuvenate ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... is, how to access caregivers and what to look for and expect when ... information. , Founded in 2006 in Canoga Park, CA by CEO, Richard Weatherman ...
Breaking Medicine News(10 mins):Health News:Inmar Announces Program to Fuel Student Passion for STEM – with an Unconventional Twist 2Health News:Dr. Brent Nelson Joins WorkCare, Inc., as Associate Medical Director 2Health News:Dr. Brent Nelson Joins WorkCare, Inc., as Associate Medical Director 3Health News:Live Webinar from Pharmaceutical Technology and METTLER TOLEDO on Calibration and Qualification of Laboratory Instruments 2Health News:Ogawa World USA Releases New Massage Chairs to the US 2Health News:Ogawa World USA Releases New Massage Chairs to the US 3Health News:AdvantagePlusCaregivers.com® Launches New Website for Corporate and Franchisee Locations in 3 States 2
... ... Award. , ... March 30, 2010 -- Five Summit Medical Group physicians have recently received the MDX/American ... M.D., Eric Mrisky, M.D., and Monib Zirvi, M.D., join their colleagues, Lisa M. Coohill, ...
... about proper use of antibiotics have the potential to ... to a report in the April issue of ... publication of the Association for Professionals in Infection Control ... MixedInk (New York, NY) studied the health information content ...
... to health with shelter dogs , TUESDAY, March 30 (HealthDay ... "leash" on life as they gain strength by walking dogs ... Cardiac Friends, is a partnership between ProHealth Care (PHC) and ... , "It,s a great way to help the dogs and ...
... Aspirin, ibuprofen and other non-steroidal anti-inflammatory drugs ... symptoms of arthritis and other inflammatory disorders. But ... have osteoarthritis) these medications are also known to ... body, particularly in the gastrointestinal tract. ...
... ... , ... -- SDI , a leading healthcare market insight and analytics firm, today reported that ... 6% in 2009 compared to 2008. The growth rate of all inpatient hospital stays that ...
... ... therapy is a major key for returning us back to our natural state as a ... ... Integrative Medicine and an Industrial Toxicologist, has dedicated a quarter of a century to discovering ...
Cached Medicine News:Health News:Summit Medical Group Physicians Receive Patients' Choice Award 2Health News:Summit Medical Group Physicians Receive Patients' Choice Award 3Health News:Misinformation about antibiotics can travel to large audience via Twitter: study 2Health News:Misinformation about antibiotics can travel to large audience via Twitter: study 3Health News:Man's Best Friend Helps Mend Broken Hearts 2Health News:Man's Best Friend Helps Mend Broken Hearts 3Health News:McMaster researcher leads development of promising drug for inflammation 2Health News:Scientist, Dr Staninger, Unlocks the Mystery of Morgellons Disease 2Health News:Scientist, Dr Staninger, Unlocks the Mystery of Morgellons Disease 3
(Date:9/1/2015)... Sept. 1, 2015 Pressure BioSciences, Inc. ... in the development and sale of broadly enabling, ... the worldwide life sciences industry, today announced the ... the Company,s PCT Platform could play a significant ... This role is based on PCT,s unique ability ...
(Date:9/1/2015)... LONDON , Sept. 1, 2015  Abbott (NYSE: ... ABSORB Japan, a multi-center, randomized trial comparing the safety ... to XIENCE ® , Abbott,s market-leading, permanent drug ... in Japan and enrolled 400 ... of heart disease. The results will be featured at ...
(Date:8/31/2015)... The Indiana Medical Device Manufacturers Council and the Indiana ... Forum to state legislators. The new policy forum was ... Indianapolis and featured two panel ... and State Sen. Brandt Hershman . Legislators also ... & Development Center, which is under construction on its ...
Breaking Medicine Technology:New Scientific Publication Suggests Pressure BioSciences' PCT Platform Could Play Significant Role in Personalized/Precision Medicine 2New Scientific Publication Suggests Pressure BioSciences' PCT Platform Could Play Significant Role in Personalized/Precision Medicine 3New Scientific Publication Suggests Pressure BioSciences' PCT Platform Could Play Significant Role in Personalized/Precision Medicine 4New Scientific Publication Suggests Pressure BioSciences' PCT Platform Could Play Significant Role in Personalized/Precision Medicine 5Abbott Announces Positive Results of Its Naturally Dissolving Stent from ABSORB Japan Study 2Abbott Announces Positive Results of Its Naturally Dissolving Stent from ABSORB Japan Study 3Abbott Announces Positive Results of Its Naturally Dissolving Stent from ABSORB Japan Study 4Indiana Lt. Gov. Sue Ellspermann and State Sen. Brandt Hershman Kick Off New Life Sciences Policy Series 2Indiana Lt. Gov. Sue Ellspermann and State Sen. Brandt Hershman Kick Off New Life Sciences Policy Series 3
... First-in-Class Biologic Treatment Option Now Available for ... Use in Pediatric Patients with JIA(1,2) -, PRINCETON, ... ) today announced that the U.S. Food and Drug,Administration (FDA) ... patients six years and older with moderately to,severely active polyarticular ...
... Model Created Using Piecewise Smooth Subdivision Surface Provides Both ... of Fallot Patients, SEATTLE, April 8, 2008 ... and volumetric insights,that help cardiologists diagnose and treat patients ... in the American Journal,Cardiology (2008; Vol. 101, Issue 1, ...
Cached Medicine Technology:U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 2U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 3U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 4U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 5U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 6U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 7U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 8U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 9U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 10Three Dimensional Visualization of Right Ventricle Provides Important Information for Treatment of Patients with Tetralogy of Fallot, According to a Study in The American Journal of Cardiology 2Three Dimensional Visualization of Right Ventricle Provides Important Information for Treatment of Patients with Tetralogy of Fallot, According to a Study in The American Journal of Cardiology 3
Complete Blink-N-Clean lens drops cleans and clears lenses in a blink. It is a unique blend of gentle to the eye ingredients that conveniently cleans, clears and keeps lenses feeling comfortable thro...
... preservative free lubricating and rewetting ... eyes while you're wearing soft ... free formula is ideal for ... to preservatives and for frequent ...
Saline Solution to rinse and store soft contact lenses and for heat disinfection....
Sensitive Eyes Plus Saline Solution to rinse soft contact lenses The unique, gentle, pH-balanced formula contains potassium, an ingredient found in tears....
Medicine Products: